SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-043182
Filing Date
2017-08-14
Accepted
2017-08-14 16:25:18
Documents
3
Period of Report
2017-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v473213_8k.htm 8-K 19468
2 EXHIBIT 99.1 v473213_ex99-1.htm EX-99.1 90732
3 GRAPHIC image_002.jpg GRAPHIC 4513
  Complete submission text file 0001144204-17-043182.txt   117948
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 171030554
SIC: 2834 Pharmaceutical Preparations